Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer. [electronic resource]
Producer: 20160922Description: 106-13 p. digitalISSN:- 1569-8041
- Abiraterone Acetate -- administration & dosage
- Adult
- Aged
- Aged, 80 and over
- Androstadienes -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Neoplasms -- drug therapy
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- Lymphatic Metastasis
- Middle Aged
- Postmenopause
- Proportional Hazards Models
- Receptors, Estrogen -- metabolism
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.